Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Clinical trial NCT01103375 · TERMINATED

Trial details

NCT number: NCT01103375
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Anaplastic Astrocytoma Adult Anaplastic Oligodendroglioma Adult Diffuse Astrocytoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Adult Oligodendroglioma Recurrent Adult Brain Tumor

Start date: 2010-05-01
Primary completion: 2013-01-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.